News
Reinforcing mesh at ostomy site prevents parastomal hernia
Prophylactic augmentation of the abdominal wall using mesh at the ostomy site prevents the development of parastomal hernia, according to a report...
Video
VIDEO: Subclinical leaflet thrombosis frequent after TAVR, SAVR
WASHINGTON – In observational data only, so far, the prevalence and severity of subclinical leaflet thrombosis was higher in TAVR valves.
News
HCV ‘cure’ within the VA appears likely
The VA has removed barriers to treatment and allocated funds for the costly but effective drugs to treat HCV.
News
Universal preterm birth screening not ready for prime time
Two screens to predict spontaneous preterm birth in low-risk women, which were rapidly adapted into clinical practice, proved to have little...
News
Stroke in AF patients often preceded by inadequate anticoagulation
More than four of five patients with atrial fibrillation who had an ischemic stroke were not taking adequate anticoagulation beforehand.
News
CF patients live longer in Canada than in U.S.
People with cystic fibrosis survive an average of 10 years longer if they live in Canada than if they live in the United States, according to a...
News
No rise in CV events seen with tocilizumab
The findings reassure that RA patients who see lipids rise while on tocilizumab don’t have a higher risk of CV events.
News
Norovirus reporting tool yields real-time outbreak data
Reporting times for epidemiologic and laboratory data can be reduced to a few days.
News
In CML, imatinib benefits persist at 10 years
Researchers are now reporting the final follow-up results for the IRIS trial after a median of 10.9 years.
News
Nemolizumab improves pruritus in atopic dermatitis
A phase II study provides evidence that a treatment targeting interleukin-31 may provide help to alleviate pruritus associated with atopic...
News
Blinatumomab superior to chemotherapy for refractory ALL
Median overall survival for patients with ALL was significantly longer with blinatumomab than with chemotherapy.
News
Sirukumab found effective, safe for highly refractory RA
The SIRROUND-T study indicates that the investigational interleukin-6 inhibitor sirukumab is safe and effective for patients with disease...
News
Rectal cancer proportion in young doubled
Colorectal cancer has been a “good news” story over the past 10-15 years. In the United States we have seen 30% reduction in both incidence and...
News
Proportion of rectal cancer in young adults doubles
Recent changes in diet and exercise patterns may be to blame.
News
Pediatric lupus patients face large burden of serious infection
Children with systemic lupus erythematosus have high rates of serious infections requiring hospitalization, especially those with lupus nephritis...